Frost & Sullivan Honors Xoft for Oncology Innovation - Earthtimes
Author : Xoft, Inc. Innovative and Cost-Effective Axxent(R) Electronic Brachytherapy System Positions Xoft, Inc. at the Forefront of Oncology Advancement SUNNYVALE, Calif., July 23 SUNNYVALE, Calif. , July 23 /PRNewswire/ — Xoft, Inc. today

Company Profile for Five Prime Therapeutics, Inc. - Forbes
Five Prime Therapeutics, Inc. is a clinical stage biotech company discovering and developing innovative protein and antibody therapeutics. FivePrime is using its world-class discovery platform to build a strong pipeline that currently includes

Three Novalis Tx(TM) Radiosurgery Platforms Ordered by Top Danish - MSN MoneyCentral
COPENHAGEN, Denmark , July 24 /PRNewswire-FirstCall/ — Varian Medical Systems VAR and BrainLAB AG are announcing that one of Scandinavia's leading cancer centers has ordered three Novalis Tx(TM) radiosurgery platforms which combine the most advanced

Bridgton officials survey Thursday's storm damage - Sun-Journal
BRIDGTON — The town's emergency management director was inspecting damage from a series of thunderstorms along the Wildwood Road Friday morning. Heavy winds and possible small tornadoes were reported as storms swept across New Hampshire and Maine

Journal of Clinical Oncology Article Highlights CellSearch Circulating - Phramalive.com
RARITAN, N.J., July 25 /PRNewswire/ — An international, prospective clinical trial found the number of circulating tumor cells (CTCs) is a strong indicator of progression-free and overall survival among metastatic colorectal cancer patients

New hope on prostate cancer - Hartford Courant
An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, researchers report. Although the study published Tuesday in the Journal of Clinical